Triptans Abroad: The Countries Where Your Migraine Prescription Runs Out

Triptans are prescription-only in most countries, OTC in a handful, and simply unavailable in several. Know before you fly.

Triptans abroad: what you need to know

Sumatriptan is the most prescribed migraine-specific medication on the planet, yet crossing a border with it can turn a managed condition into a pharmacological emergency. The problem is not that triptans are exotic. The problem is inconsistency: the same molecule is sold over the counter in the United Kingdom, locked behind a specialist prescription in Japan, and simply not registered for sale in several low- and middle-income countries.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Drug availability, prescription requirements, and importation rules change. Verify current regulations with the relevant national medicines authority or your prescribing physician before you travel.

Why triptans behave differently in every country

Drug scheduling is set by each national regulator independently. Sumatriptan, zolmitriptan, and rizatriptan are approved and commercially available in most high-income countries, but the prescription status varies significantly between jurisdictions^[1]. That variation is the single largest practical obstacle for migraine travellers.

Three regulatory tiers exist in practice. First, countries where triptans are available without a prescription at a pharmacy counter. Second, countries where a local prescription from a licensed physician is required before any pharmacy will dispense. Third, countries where no triptan has received marketing authorisation at all.

Where you can buy triptans without a prescription

Sumatriptan 50 mg is classified as a pharmacy-only medicine in the United Kingdom^[2], meaning a pharmacist can sell it after a brief consultation without a doctor's prescription. The same applies in Ireland and several Nordic countries for low-dose oral formulations. If you are already stable on a triptan and you forget a dose at the airport, these countries give you a practical fallback.

The catch is that pharmacist-led sales still carry a clinical gatekeeping step. You may be asked about cardiovascular history, contraindications, and previous diagnosis. Without a legible prescription or a summary of your diagnosis, the consultation can stall. A structured medical record helps considerably here.

Countries where a local prescription is mandatory

In Japan, all triptans require a domestic prescription^[3] from a licensed Japanese physician. Your prescription from abroad does not transfer. Sumatriptan (sold as Imigran), zolmitriptan (Zomig), and eletriptan (Relpax) are all registered and dispensed through hospital or clinic pharmacies. The process to obtain a prescription as a visitor involves an outpatient neurology or internal medicine consultation, which costs roughly ¥3,000 to ¥6,000 (~$20 to ~$40 / ~€18 to ~€37) with a health insurance contribution.

The United States requires a prescription for all triptans. Without one, no retail pharmacy will dispense. An urgent care visit or telehealth consultation typically costs $75 to $150 (~€70 to ~€140) without insurance. Several telehealth platforms operating in the US can issue a prescription within hours if you have documented migraine history.

In the European Union, prescription requirements are set nationally rather than at EU level. France, Germany, and Spain all classify triptans as prescription-only medicinal products under EU Directive 2001/83/EC^[4]. A foreign prescription is theoretically recognisable under EU rules, but individual pharmacists in these countries exercise discretion, and many decline to fill non-domestic prescriptions. Bringing a sufficient supply from home is the safest approach.

Countries where triptans are not available at all

Several countries in sub-Saharan Africa, parts of Central Asia, and some Pacific island nations have not registered any triptan with their national medicine authority. The WHO Model List of Essential Medicines has included sumatriptan since 2021, but inclusion on the Model List does not oblige governments to register or procure a drug. Access to migraine-specific treatments in low-income countries^[5] remains a documented global health gap. If you are travelling to a country where you cannot verify local availability, bring your full supply plus a calculated buffer for delays.

Morocco, Nepal, and many destinations in West Africa fall into a grey zone: triptans may be theoretically importable under personal-use allowances, but local pharmacies do not stock them. Running out mid-trip means managing attacks with non-specific analgesics such as ibuprofen or paracetamol combined with an antiemetic.

Importing your own supply: what the rules actually say

Triptans are not controlled substances under the UN international drug conventions, so personal importation is generally unrestricted up to a reasonable supply quantity. Most countries permit a personal supply of up to 90 days^[6] of non-controlled medications for personal use, provided you carry a valid prescription and the medication is in original packaging with your name on the label.

Japan is stricter. Personal importation of prescription medications including triptans is technically permitted under the Yunyu Kakunin-sho declaration system for a one-month supply, but the documentation burden is high. Carry a doctor's letter in both English and Japanese if possible.

Gulf states require advance approval for any imported prescription medicine, including triptans. In the UAE, that approval is now issued by the Emirates Drug Establishment (EDE) at ede.gov.ae (the personal-import service migrated from MoHAP on 29 December 2025). Saudi Arabia, Qatar, and Kuwait require similar approval through their respective health ministries. Allow two to four weeks to obtain authorisation before travel if you are visiting these countries with a substantial supply.

CGRP antagonists and newer migraine drugs

If you use rimegepant (Nurtec ODT / Vydura), ubrogepant (Ubrelvy), or lasmiditan (Reyvow), availability is narrower than for the older triptans. Rimegepant has the broadest reach — EMA approval for both acute and preventive migraine since May 2022 (Vydura), and a Pfizer launch in Japan in December 2023 (Nurtec). Ubrogepant and lasmiditan remain primarily US-registered, with limited or no marketing authorisation across Southeast Asia, most of Latin America, and most of Africa as of 2026. Bring your full supply rather than expecting to refill locally outside the US or EU.

Lasmiditan is a Schedule V controlled substance in the US, which adds a layer of complexity to importation into countries with strict narcotics import rules. Check the destination country's regulations specifically if lasmiditan is your acute treatment.

Preventive medications: a separate set of complications

Monthly CGRP monoclonal antibodies such as erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality) are cold-chain medications. They require refrigeration between 2°C and 8°C and must not freeze. Airport security is not the risk; the hotel minibar is. Confirm that your accommodation has a dedicated refrigerator before you book.

These biologics are not registered in many countries outside Europe, North America, Australia, and Japan. Do not plan to resupply locally on a long trip. They are also expensive: a single monthly dose of erenumab costs approximately $700 (~€650) in the US without insurance subsidy. Bring what you need.

What to carry and how to document it

Understanding medication import rules before you travel saves significant time at the pharmacy counter. For CGRP biologics, knowing cold-chain medication requirements is equally critical.

A prescription letter from your neurologist or GP should include: your name and date of birth, the drug's generic name and brand name, the dose and frequency, the diagnosis in plain language, and the prescriber's contact details. One page, on headed paper, is the standard expected format at most borders and pharmacies.

An International Patient Summary adds a machine-readable layer on top of the letter. It lists your medications, diagnoses, allergies, and relevant history in a structured format that emergency clinicians and pharmacists abroad can parse quickly. A medication passport on your phone can bridge the language gap when a paper letter in your home language means nothing to a pharmacist in Bangkok or Nairobi.

A country-by-country quick reference

The following reflects the most common scenarios for sumatriptan specifically. Always verify current status with the national medicines agency before you travel.

United Kingdom, Ireland: pharmacy-only, no prescription required for 50 mg oral
France, Germany, Spain, Italy: prescription-only; foreign prescriptions accepted at pharmacist's discretion
United States, Canada: prescription-only; telehealth can bridge a gap quickly
Japan: prescription-only from domestic physician; personal import capped at one month
Thailand, South Korea, Taiwan: registered and prescription-only; private clinics can prescribe on same day
Morocco, Nepal, many sub-Saharan African markets: limited or no local availability; bring full supply

UAE, Saudi Arabia: registered; advance import approval required for personal supply (UAE: Emirates Drug Establishment / ede.gov.ae)

The one preparation step most travellers skip

Most migraine travellers focus on bringing enough medication. Fewer verify what the brand name is called at their destination. Sumatriptan is sold as Imigran in the UK and Japan, Imitrex in the US and Canada, and Sumas or generic sumatriptan in parts of Europe. If you need to communicate your medication to a local clinician, the brand name they know may not be yours.

The generic name, sumatriptan, is the safe universal anchor. Any clinician or pharmacist globally who recognises the drug at all will recognise the INN. Write it on your documentation in addition to your local brand name.

Before any long-haul trip, generate your International Patient Summary on Nomedic. It stores your migraine medications using INN terminology, attaches your diagnosis, and produces a PDF that works in any country regardless of language or local brand name conventions.

Frequently asked questions

Can I bring sumatriptan on a plane?

Yes. Triptans are not controlled substances under international conventions, so airport security does not restrict them. Keep medication in original packaging with your name on the label and carry a prescription letter. Some countries have personal import quantity limits, typically 30 to 90 days' supply.

Can I buy sumatriptan at a pharmacy in France without a prescription?

No. France classifies sumatriptan as a prescription-only medicine. A French pharmacist will not dispense it without a valid prescription. Foreign prescriptions are accepted at the pharmacist's discretion, so carrying your home prescription and a doctor's letter is advisable, but bringing a sufficient supply is the safest approach.

What should I do if I run out of triptans abroad in a country where they are not available?

Seek a consultation at a private clinic or emergency outpatient department. Explain your migraine history and ask whether sumatriptan can be sourced through a hospital pharmacy, which sometimes carries medications unavailable at retail. Non-triptan options including high-dose NSAIDs and antiemetics can reduce attack severity while you arrange a resupply.

Do CGRP monoclonal antibodies (Aimovig, Ajovy, Emgality) need special import documentation?

They are not controlled substances, but they are cold-chain medications requiring continuous refrigeration. You will need a prescription letter and evidence of your diagnosis for customs purposes. Cold-chain packaging for air travel is available through medical supply companies and your prescribing specialist can often advise on logistics.

Are newer migraine drugs like rimegepant available outside the United States?

Rimegepant (Nurtec ODT) received EU approval as Vydura in 2022, expanding availability to European markets. It is not yet approved in most of Asia, Latin America, or Africa as of mid-2025. Ubrogepant and lasmiditan remain US-only approvals. If you use these medications, bring your full travel supply.

Is a doctor's letter enough to import my migraine medication into Japan?

For a supply of up to one month, a prescription or doctor's letter is the minimum required documentation under Japan's personal import declaration system. The letter should include the drug's generic name, your name, the dose, and the prescribing physician's details. Quantities beyond one month's supply require a Yunyu Kakunin-sho certificate from Japan's Ministry of Health, Labour and Welfare.